Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.03.19.644090

Cross-Frequency Coupling as a Neural Substrate for Prediction Error Evaluation: A Laminar Neural Mass Modeling Approach

Abstract

Predictive coding frameworks suggest that neural computations rely on hierarchical error minimization, where sensory signals are evaluated against internal model predictions. However, the neural implementation of this inference process remains unclear. We propose that cross-frequency coupling (CFC) furnishes a fundamental mechanism for this form of inference. We first demonstrate that our previously described Laminar Neural Mass Model (LaNMM) supports two key forms of CFC: (i) Signal-Envelope Coupling (SEC), where lowfrequency rhythms modulate the amplitude envelope of higher-frequency oscillations and (ii) Envelope-Envelope Coupling (EEC), where the envelopes of slower oscillations modulate the envelopes of higher-frequency rhythms. Then, we propose that, by encoding information in signals and their envelopes, these processes instantiate a hierarchical "Comparator" mechanism at the columnar level. Specifically, SEC generates fast prediction-error signals by subtracting top-down predictions from bottom-up oscillatory envelopes, while EEC operates at slower timescales to instantiate gating--a critical computational mechanism for precision-weighting and selective information routing. To establish the face validity and clinical implications of this proposal, we model perturbations of these CFC mechanisms to investigate their roles in pathophysiological and altered neuronal function. We illustrate how, in disorders such as Alzheimers disease, disruptions in gamma oscillations following dysfunction in fast-spiking inhibitory interneurons impact Comparator function with an aberrant amplification of prediction errors in the early stages and a drastic attenuation in late phases of the disease. In contrast, by increasing excitatory gain, serotonergic psychedelics diminish the modulatory effect of predictions, resulting in a failure to attenuate prediction error signals (c.f., a failure of sensory attenuation). Collectively, these findings implicate cross-frequency coupling across multiple temporal scales as a key computational mechanism supporting predictive coding and suggest that disruptions in these processes play a central role in disease. HighlightsO_LIUsing an encoding scheme where information is encoded in signals, their envelopes, and envelopes of envelopes, we show how to implement prediction error and precision modulation in a neural mass model through cross-frequency coupling (CFC). C_LIO_LIWe use the laminar neural mass model (LaNMM), which integrates Jansen-Rit and pyramidal interneuron gamma (PING) submodels to display fast and slow rhythms and provides mechanisms for a) Signal-Envelope Coupling (SEC), where slow-wave activity modulates the amplitude envelope of fast oscillations (analogous to phase-amplitude coupling), and b) Envelope-Envelope Coupling (EEC), where the envelopes of slower oscillations modulate the envelopes of higher-frequency rhythms. C_LIO_LIWe show how to use the LaNMM to implement information-based prediction-error evaluation (as used in Active Inference and Kolmogorov Theory), computing the approximate precision-weighted difference between incoming sensory data (envelopes) and internal model predictions (signals or envelopes). C_LIO_LIWe show that using these mechanisms, the Comparator mechanism can operate at multiple levels and timescales, generating fast prediction-error signals (via SEC) and slower gating signals that encode context (e.g., precision) (via EEC). C_LIO_LIOur model provides insights into the physiological and cognitive consequences of mesoscale circuital alterations in the context of predictive coding. First, we study disorders of fast-spiking interneurons, such as Alzheimers Disease (AD). In the early stages of AD, error evaluation and precision are disrupted (inflated error and reduced gating/weight of predictions), leading to higher prediction errors. In later stages, prediction errors are suppressed regardless of predictions or their precision. C_LIO_LIThen, we show how serotonergic psychedelics increase the effective weight of inputs and diminish that of predictions, resulting in higher prediction error signals. C_LIO_LIThese observations link oscillatory mechanisms and predictive coding alterations, and potentially with the subjective phenomena in each condition--including cognitive decline in AD and hallucinatory states under psychedelics. C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ruffini, G., Lopez-Sola, E., Palma, R., Vohryzek, J., Castaldo, F., Friston, K.. 2025-03-19. Cross-Frequency Coupling as a Neural Substrate for Prediction Error Evaluation: A Laminar Neural Mass Modeling Approach. https://doi.org/10.1101/2025.03.19.644090

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗